TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30557747

Group type: EXPERIMENTAL
Intervention: Own-race stimuli
Number of subjects: 136

Group type: COMPARATOR
Intervention: Other-race stimuli
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Associative training task with arbitrary visual stimuli
Number of subjects: 136
Study: 28509584

Group type: EXPERIMENTAL
Intervention: Elbow Flexed (EF) crutch setup
Number of subjects: 30

Group type: COMPARATOR
Intervention: Elbow Straight (ES) crutch setup
Number of subjects: 30
Study: 26227494

Group type: EXPERIMENTAL
Intervention: Diaphragm biofeedback training (DBT) + rabeprazole proton pump inhibitor (PPI)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Rabeprazole alone
Number of subjects: 40
Study: 24745020

Group type: EXPERIMENTAL
Intervention: Preemptive thoracic epidural analgesia (TEA) administered as a bolus before surgical incision and continued until the end of surgery.
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Preemptive thoracic epidural analgesia (TEA)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Conventional postoperative epidural analgesia
Number of subjects: 44
Study: 22697440

Group type: EXPERIMENTAL
Intervention: Transdiagnostic cognitive-behavioral treatments (CBT) for anxiety disorders, 12-week duration
Number of subjects: 87

Group type: COMPARATOR
Intervention: Comprehensive relaxation training program, 12-week duration
Number of subjects: 87
Study: 18973896

Group type: EXPERIMENTAL
Intervention: Cyclic oral contraceptive therapy (low-dose, monophasic OCP for 24 months)
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Continuous oral contraceptive therapy (low-dose, monophasic OCP for 24 months)
Number of subjects: 239

Group type: COMPARATOR
Intervention: No therapy (nonusers)
Number of subjects: 239
Study: 18928120

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) of Sanyinjiao (SP 6), 2/100 Hz, 8‐10 mA, 3 times a week for 3 months
Number of subjects: 157

Group type: COMPARATOR
Intervention: Medication group (oral nylestriol, 2 mg/time, twice a month for 3 months, with medroxyprogesterone from the third month)
Number of subjects: 157
Study: 15970467

Group type: EXPERIMENTAL
Intervention: Psychiatric case management (exact details of dosage and duration not available)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Length of hospitalizations (only hospitalized patients included)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multi-state modeling approach (exact details of intervention not available)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Proportional hazards regression (exact details of intervention not available)
Number of subjects: 0
Study: 11879261

Group type: COMPARATOR
Intervention: Sildenafil 50 mg
Number of subjects: 33

Group type: COMPARATOR
Intervention: Sildenafil 100 mg
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 12490113

Group type: EXPERIMENTAL
Intervention: Oral acyclovir at 300 mg/day for 1 year (prophylaxis group)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group (no specific treatment mentioned)
Number of subjects: 105
Study: 9531028

Group type: EXPERIMENTAL
Intervention: Dalteparin, 120 IU/kg bw twice daily for 5-8 days and 7,500 IU once daily for 35-40 days
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: Dalteparin, lower dose after initial high dose
Number of subjects: 342

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 342
Study: 7973213

Group type: EXPERIMENTAL
Intervention: Hormonal therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 2691638

Group type: EXPERIMENTAL
Intervention: Relaxation training
Number of subjects: 40

Group type: COMPARATOR
Intervention: Tension inducement
Number of subjects: 40

Group type: COMPARATOR
Intervention: Pre‐postcontrol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Postcontrol
Number of subjects: 40
Study: 30869182

Group type: EXPERIMENTAL
Intervention: Colchicine 0.6 mg twice daily for 3 months
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 29162572

Group type: EXPERIMENTAL
Intervention: Antistigma intervention consisting of staff training, raising awareness, a recovery-focused art programme, and analysis of internal policies and procedures.
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 6
Study: 26494108

Group type: EXPERIMENTAL
Intervention: Research‐based Developmentally Informed (REDI) Parent program (REDI‐P)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Mail‐home math games (comparison condition)
Number of subjects: 200
Study: 23736109

Group type: EXPERIMENTAL
Intervention: Antihypertensive medications (average of 1.7 medications)
Number of subjects: 3020
Study: 21982138

Group type: EXPERIMENTAL
Intervention: Massage therapy
Number of subjects: 46

Group type: COMPARATOR
Intervention: Standard treatment control
Number of subjects: 46
Study: 18646481

Group type: EXPERIMENTAL
Intervention: Laparoscopic Heller myotomy with concomitant anterior fundoplication
Number of subjects: 353

Group type: COMPARATOR
Intervention: Laparoscopic Heller myotomy alone
Number of subjects: 353
Study: 16574546

Group type: EXPERIMENTAL
Intervention: D3 surgery
Number of subjects: 221

Group type: COMPARATOR
Intervention: D1 surgery
Number of subjects: 221
Study: 12612295

Group type: EXPERIMENTAL
Intervention: Montelukast 10 mg + inhaled budesonide 800 microg/day
Number of subjects: 889

Group type: COMPARATOR
Intervention: Double dose inhaled budesonide 1600 microg/day
Number of subjects: 889
Study: 10832071

Group type: EXPERIMENTAL
Intervention: CoQ(10) supplementation (50 mg three times daily)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: CoQ(10) supplementation
Number of subjects: 12
Study: 9103798

Group type: EXPERIMENTAL
Intervention: Electric toothbrush designed specifically for children
Number of subjects: 0

Group type: COMPARATOR
Intervention: Children's manual toothbrush
Number of subjects: 0
Study: 8194411

Group type: EXPERIMENTAL
Intervention: Sialography with the time-pressure curve monitored
Number of subjects: 66

Group type: COMPARATOR
Intervention: Manual injection technique
Number of subjects: 66
Study: 31838443

Group type: EXPERIMENTAL
Intervention: CBT/Integrated
Number of subjects: 119

Group type: COMPARATOR
Intervention: CBT/SUD
Number of subjects: 119
Study: 31209657

Group type: EXPERIMENTAL
Intervention: Venetoclax in combination with Rituximab
Number of subjects: 182
Study: 28359283

Group type: EXPERIMENTAL
Intervention: Differentiated muscle training exercises concomitant to radiotherapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Progressive muscle relaxation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Differentiated muscle training exercises
Number of subjects: 60
Study: 25613938

Group type: EXPERIMENTAL
Intervention: Intravitreal injection of bevacizumab (IVB) at 0.625 mg per eye per dose
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Intravitreal injection of bevacizumab (IVB) at 0.25 mg per eye per dose
Number of subjects: 24

Group type: COMPARATOR
Intervention: Laser treatment
Number of subjects: 24
Study: 23663798

Group type: EXPERIMENTAL
Intervention: Physical activity program
Number of subjects: 273

Group type: COMPARATOR
Intervention: Social support program
Number of subjects: 273

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 273
Study: 21807052

Group type: EXPERIMENTAL
Intervention: 25 μg dose of parvovirus B19 recombinant capsid
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: 2.5 μg dose of recombinant capsid with MF59
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: 25 μg dose of recombinant capsid with MF59
Number of subjects: 43

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 43
Study: 19553184

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin tablets
Number of subjects: 7

Group type: COMPARATOR
Intervention: Dissolution test as quality tool
Number of subjects: 7
Study: 16715957

Group type: EXPERIMENTAL
Intervention: Ordered subsets expectation maximization (OSEM)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Filtered backprojection (FBP)
Number of subjects: 14
Study: 15744699

Group type: EXPERIMENTAL
Intervention: Fondaparinux 2.5 mg once-daily subcutaneous regimen starting postoperatively
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fondaparinux 4 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enoxaparin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fondaparinux 1 week
Number of subjects: 0
Study: 11120907

Group type: EXPERIMENTAL
Intervention: Erythromycin (1-100 microg/ml)
Number of subjects: 0

Group type: COMPARATOR
Intervention: IL-8
Number of subjects: 0

Group type: COMPARATOR
Intervention: f-Met-Leu-Phe (fMLP)
Number of subjects: 0
Study: 9465382

Group type: EXPERIMENTAL
Intervention: Swanson Silastic spacer with titanium grommets (Gr. I)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Swanson Silastic spacer without titanium grommets (Gr. II and Gr. III)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Swanson Silastic spacer without titanium grommets (Gr. II)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Swanson Silastic spacer without titanium grommets (Gr. III)
Number of subjects: 250
Study: 7934344

Group type: EXPERIMENTAL
Intervention: Bathing in coastal waters (total immersion of the head)
Number of subjects: 1216

Group type: EXPERIMENTAL
Intervention: Faecal streptococci concentration measured at chest depth
Number of subjects: 1216
Study: 3791269

Group type: EXPERIMENTAL
Intervention: Methylphenidate (10 mg with breakfast and 5 mg with lunch for 3 days)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 32
Study: 29442148

Group type: EXPERIMENTAL
Intervention: 180 mg ticagrelor
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 30 mg maintenance dose (MD)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Routine clinical dosage regimen (180 mg LD, 90 mg MD)
Number of subjects: 14
Study: 27138229

Group type: EXPERIMENTAL
Intervention: BTX‐A
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control
Number of subjects: 30
Study: 25668998

Group type: EXPERIMENTAL
Intervention: Intravenous dexmedetomidine 0.5 μg/kg followed by epidural dexmedetomidine 0.5 μg/kg along with 5 ml; 0.25% ropivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intravenous fentanyl 1 μg/kg followed by epidural fentanyl 1 μg/kg along with 5 ml; 0.25% ropivacaine
Number of subjects: 60
Study: 24622263

Group type: EXPERIMENTAL
Intervention: daglutril (300 mg/day)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: daglutril
Number of subjects: 45
Study: 20834187

Group type: EXPERIMENTAL
Intervention: Lifestyle modification program
Number of subjects: 54
Study: 18589484

Group type: EXPERIMENTAL
Intervention: ABC/3TC
Number of subjects: 0

Group type: COMPARATOR
Intervention: TDF/FTC
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ritonavir-boosted PIs (FPV/r and LPV/r)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DRV/r
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Etravirine, Raltegravir, Maraviroc
Number of subjects: 0
Study: 16782685

Group type: EXPERIMENTAL
Intervention: Stuttering Treatment Research Evaluation and Assessment Tool (STREAT)
Number of subjects: 0
Study: 14516239

Group type: EXPERIMENTAL
Intervention: Internet intervention (Web)
Number of subjects: 24

Group type: COMPARATOR
Intervention: No Internet intervention (No-Web)
Number of subjects: 24
Study: 10743799

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine sulfate (HCQ)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo (delayed treatment)
Number of subjects: 119
Study: 8692115

Group type: EXPERIMENTAL
Intervention: Allogeneic BMT
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: High-dose cytosine-arabinoside/daunorubicin (HDAC)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Autologous BMT
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: HDAC (2 cycles)
Number of subjects: 148

Group type: COMPARATOR
Intervention: HDAC (1 cycle)
Number of subjects: 148
Study: 1741218

Group type: EXPERIMENTAL
Intervention: Electric pulsatile pump
Number of subjects: 23

Group type: COMPARATOR
Intervention: Other artificial pumping methods
Number of subjects: 23

Group type: COMPARATOR
Intervention: Natural infant suckling
Number of subjects: 23

Group type: COMPARATOR
Intervention: All methods (including artificial and natural)
Number of subjects: 23
Study: 6385835

Group type: EXPERIMENTAL
Intervention: Empirical tobramycin and ticarcillin for 3 days
Number of subjects: 50

Group type: COMPARATOR
Intervention: Empirical tobramycin and ticarcillin until afebrile and no longer granulocytopenic
Number of subjects: 50
Study: 31369152

Group type: EXPERIMENTAL
Intervention: Nitrous oxide-based anesthetic (N2 O with propofol and remifentanil)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Total intravenous anesthesia (TIVA with propofol and remifentanil)
Number of subjects: 0
Study: 30882355

Group type: EXPERIMENTAL
Intervention: Clinical virtual simulation (experimental group, n=21)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Low-fidelity simulator and realistic environment (control group, n=21)
Number of subjects: 42
Study: 29237510

Group type: EXPERIMENTAL
Intervention: Posterior left pericardiotomy
Number of subjects: 350

Group type: COMPARATOR
Intervention: Control group (no posterior left pericardiotomy)
Number of subjects: 350
Study: 25454683

Group type: EXPERIMENTAL
Intervention: Spinal manipulative therapy (SMT) with home exercise
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Supervised plus home exercise
Number of subjects: 241

Group type: COMPARATOR
Intervention: Home exercise alone
Number of subjects: 241
Study: 24428802

Group type: EXPERIMENTAL
Intervention: Dietary behavior modification treatment (1.5 hours of individual counseling at study start, 1 hour at follow-up home visits after 6 weeks, support through cell phone text messages every two weeks, aimed to reduce dietary intake by 500 kcal/day)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 68
Study: 22950829

Group type: EXPERIMENTAL
Intervention: P6 acupressure device placed on the P6 acupressure point in Group A patients.
Number of subjects: 204

Group type: COMPARATOR
Intervention: Placebo group with inappropriate placement of device on the dorsal part of the carpus in Group B patients.
Number of subjects: 204
Study: 19681413

Group type: EXPERIMENTAL
Intervention: Fentanyl 2.5 microg x kg(‐1)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.5 microg x kg(‐1)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Saline solution (Control)
Number of subjects: 90
Study: 17718363

Group type: EXPERIMENTAL
Intervention: Coarse scale of image resolution (10 pixels per face)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Finer scale of image resolution (17 pixels per face)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Coarse scale of image resolution
Number of subjects: 0
Study: 15266079

Group type: EXPERIMENTAL
Intervention: 40K activity in females
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Total body potassium (TBK) in females
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 40K activity in males
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Total body potassium (TBK) in males
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Average TBK for males aged 20-49 years
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Average potassium concentrations for males
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Potassium concentrations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Future work
Number of subjects: 0
Study: 11124689

Group type: EXPERIMENTAL
Intervention: COBE Spectra Version 4.7
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: COBE Spectra Version 6
Number of subjects: 20

Group type: COMPARATOR
Intervention: Haemonetics MCS+
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: All machines
Number of subjects: 20
Study: 9166373

Group type: EXPERIMENTAL
Intervention: Emerging therapies for multiple sclerosis management, specific therapies not detailed, duration not specified.
Number of subjects: 0
Study: 8319063

Group type: EXPERIMENTAL
Intervention: 0.5 g of a negative oral contrast agent (oral magnetic particles) administered in 800 ml of a viscous suspension
Number of subjects: 40

Group type: COMPARATOR
Intervention: Pre-contrast MRI series
Number of subjects: 40
Study: 3565937

Group type: EXPERIMENTAL
Intervention: Hyperoxia (15 min)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Air (Control)
Number of subjects: 17
Study: 31425479

Group type: EXPERIMENTAL
Intervention: Ipilimumab
Number of subjects: 1136

Group type: COMPARATOR
Intervention: Non-ipilimumab control treatments
Number of subjects: 1136
Study: 30277862

Group type: EXPERIMENTAL
Intervention: rilonacept (320 mg loading dose at day 0, then 160 mg for 5 subsequent weekly doses)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: rilonacept
Number of subjects: 19

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 19
Study: 26882015

Group type: EXPERIMENTAL
Intervention: Pafuramidine (100 mg orally twice a day for 10 days)
Number of subjects: 273

Group type: COMPARATOR
Intervention: Pentamidine (4 mg/kg intramuscularly once daily for 7 days)
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Pafuramidine
Number of subjects: 273

Group type: COMPARATOR
Intervention: Pentamidine
Number of subjects: 273
Study: 24993817

Group type: EXPERIMENTAL
Intervention: Beclometasone/formoterol DPI (children: 200 μg/24 μg, adolescents/adults: 400 μg/24 μg)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Beclometasone/formoterol DPI (adolescents/adults: 400 μg/24 μg)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Normalization for BDP/formoterol dose
Number of subjects: 85
Study: 21737312

Group type: EXPERIMENTAL
Intervention: Individualized intervention to foster optimal antiretroviral treatment-taking behavior
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 51
Study: 19568773

Group type: EXPERIMENTAL
Intervention: Aprepitant triple-therapy regimen (aprepitant, ondansetron, and dexamethasone)
Number of subjects: 848

Group type: COMPARATOR
Intervention: Control regimen (ondansetron and dexamethasone)
Number of subjects: 848
Study: 18192791

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Macrolides (including azithromycin)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Penicillin
Number of subjects: 0
Study: 16444998

Group type: EXPERIMENTAL
Intervention: Adenosine triphosphate (ATP)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Dipyridamole (DIP)
Number of subjects: 21
Study: 12578455

Group type: EXPERIMENTAL
Intervention: Fluorouracil (0.5‐mg/mL) applied to the rhinostomy site for 5 minutes during surgery
Number of subjects: 155

Group type: COMPARATOR
Intervention: Control group (isotonic sodium chloride solution) applied to the rhinostomy site for 5 minutes during surgery
Number of subjects: 155
Study: 11194594

Group type: EXPERIMENTAL
Intervention: DDDR + consistent atrial pacing mode
Number of subjects: 15

Group type: COMPARATOR
Intervention: DDDR
Number of subjects: 15
Study: 8639069

Group type: EXPERIMENTAL
Intervention: Subcutaneous dihydroergotamine mesylate (1 mg)
Number of subjects: 295

Group type: COMPARATOR
Intervention: Subcutaneous sumatriptan succinate (6 mg)
Number of subjects: 295
Study: 2062512

Group type: EXPERIMENTAL
Intervention: Early photocoagulation (scatter and focal treatment)
Number of subjects: 3711

Group type: COMPARATOR
Intervention: Deferral of photocoagulation
Number of subjects: 3711

Group type: EXPERIMENTAL
Intervention: Focal photocoagulation
Number of subjects: 3711

Group type: EXPERIMENTAL
Intervention: Scatter photocoagulation
Number of subjects: 3711

Group type: EXPERIMENTAL
Intervention: Less extensive scatter photocoagulation
Number of subjects: 3711
Study: 6852359

Group type: EXPERIMENTAL
Intervention: CDCA (750 mg/day in three divided doses at meals)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 29728286

Group type: EXPERIMENTAL
Intervention: Supervised Physical Activity Program (120 min/week with sociocultural activities once a month)
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: Supervised Physical Activity Program
Number of subjects: 364
Study: 29753321

Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) concentrations in patients with Gram-negative bacteremia
Number of subjects: 6561

Group type: COMPARATOR
Intervention: Procalcitonin (PCT) concentrations in patients with Gram-positive bacteremia or candidemia
Number of subjects: 6561

Group type: EXPERIMENTAL
Intervention: Receiver operating curve analysis for prediction of Gram-negative bacteremia
Number of subjects: 6561

Group type: EXPERIMENTAL
Intervention: Optimized cutoff value for PCT
Number of subjects: 6561

Group type: EXPERIMENTAL
Intervention: PCT concentrations in relation to specific pathogens
Number of subjects: 6561

Group type: EXPERIMENTAL
Intervention: PCT concentrations in relation to foci of infection
Number of subjects: 6561

Group type: EXPERIMENTAL
Intervention: Linear regression model for PCT values
Number of subjects: 6561
Study: 26297598

Group type: EXPERIMENTAL
Intervention: Food Dudes program with tangible prizes
Number of subjects: 2292

Group type: EXPERIMENTAL
Intervention: Food Dudes program with teacher praise
Number of subjects: 2292

Group type: COMPARATOR
Intervention: Food Dudes program (both prize and praise)
Number of subjects: 2292
Study: 25475460

Group type: EXPERIMENTAL
Intervention: Early invasive strategy after fibrinolysis
Number of subjects: 992
Study: 22269820

Group type: EXPERIMENTAL
Intervention: Continuous infusion of cisatracurium (0.78 ± 0.15 μg.kg(‐1).min(‐1))
Number of subjects: 30

Group type: COMPARATOR
Intervention: Intermittent bolus injection of cisatracurium (1.09 ± 0.33 μg.kg(‐1).min(‐1))
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Continuous infusion of cisatracurium
Number of subjects: 30

Group type: COMPARATOR
Intervention: Intermittent bolus injection of cisatracurium
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study: 20578382

Group type: EXPERIMENTAL
Intervention: Single usage of acupoints of Shaoyang meridian (Fengchi (GB 20), Yifeng (TE 17), Wangu (GB 12) at the affected side) from the 3rd day to the 14th day, followed by routine acupoints (Hegu (LI 4) on both sides, Fengchi (GB 20), Quchi (LI 11), Yangbai (GB 14) at the affected side) after the 15th day, along with oral Prednisone.
Number of subjects: 120

Group type: COMPARATOR
Intervention: Routine acupoints (same as the routine ones in the observation group) from the 3rd day, along with oral Prednisone.
Number of subjects: 120